FT Global Pharmaceutical and Biotechnology Conference

Key Topics

• How China’s novel approaches to R&D, data and digital health are creating innovate treatment and service models
• The role of super clusters and industrial strategy in creating a ‘big bang’ in life sciences
• How innovative gene-based therapies are transforming the industry paradigm from treatment to cure and the pricing strategies to manage it
• What it takes for pharma to win in population health management and the business of prevention
• Where they are placing bets in pharma
• The future of diagnostics and personalised medicine
• Value and evidence and the challenge of managing the increasing volume and complexity of big data

Who should Attend

• Biotechnology companies
• Pharmaceutical companies
• CROs
• Diagnostic and medical device
• Government healthcare departments, HTA’s and drug regulators
• Healthcare providers and insurers
• Health economists
• IT, big data and analytics providers
• Patient representatives and NGOs
• Healthcare investment bankers, private equity